Related Experiment Video
Updated: May 7, 2026
09:00
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
7.8K
Efficient CRISPR-Cas RNP-based gene targeting of human AT2 cells
Tristan Kooistra1,2, Tresa R Sarraf1,2, Michelle Chen1,2
1Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States.
Summary
Researchers developed a fast, cost-effective CRISPR ribonucleoprotein (RNP) method for genetically modifying primary human alveolar type 2 (AT2) cells. This breakthrough enables efficient gene editing in lung epithelial cells, advancing the study of lung biology.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Genetic Engineering
Background:
- Alveolar type 2 (AT2) cells are crucial for lung function, possessing stem cell, immunoregulatory, and secretory roles.
- Primary human AT2 cells can be cultured as organoids, but genetic manipulation is challenging and costly.
- Current methods involve viral vectors or induced pluripotent stem cells (iPSCs), which are inefficient and time-consuming.
Purpose of the Study:
- To establish a high-efficiency, rapid, and cost-effective method for genetic manipulation of primary human AT2 cells.
- To enable deeper investigation into the role of the alveolar epithelium in human lung biology.
Main Methods:
- Utilized an optimized CRISPR ribonucleoprotein (RNP) complex for gene editing.
- Applied the method to cultured primary human AT2 cells.
- Focused on achieving efficient genetic knockout while maintaining cell viability and identity.
Main Results:
- Achieved nearly complete genetic knockout in primary human AT2 cells.
- Preserved the identity and viability of AT2 cells post-gene editing.
- Demonstrated a significantly faster and more cost-effective approach compared to existing methods.
Conclusions:
- The optimized CRISPR RNP method simplifies genetic manipulation of human AT2 cells.
- This technique facilitates research into the alveolar epithelium's function in lung health and disease.
- Provides a valuable tool for advancing pulmonary research and therapeutic development.
